Bachem to Conclude Integration of Sochinaz by June
Bachem would successfully conclude the integration of fine chemicals firm Sochinaz into the group as of June 30.
Bachem, a Swiss supplier of peptide active ingredients for the pharmaceutical and biotech industries, announced that it would complete the integration of fine chemicals firm Sochinaz by 30 June.
The Sochinaz plant in Vionnaz will operate as a branch of Bachem, based in Bubendorf, with the same product line and services.
Bachem says combining the organisational units of the two locations will produce synergies in both sales and marketing and research and development. Currently around 100 people work at Vionnaz and no jobs cuts are envisaged.
Bachem Group chief executive Dr Rolf Nyfeler, said: ‘Having now completed the integration of Sochinaz and restructured our US operations last year, Bachem has put in
Related News
-
News Strategies for managing an outsourcing partner
Robust oversight linked to increased efficiency and better communication with outsourcing partners. -
News Updated: CPHI North America 2022 Blog
Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. -
News Greater standardisation needed for effective ESG reporting - Expert panel
Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. -
News MedPharm: Increased investment driving developments in topical drugs market
We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. -
News Pharmapack Awards 2022: Winners Revealed
The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. -
News What it means to be 'At the heart of Pharma'
Informa Markets colleagues explain the motivations behind CPHI’s rebrand. -
News CPhI Podcast Series: Leveraging data science for sustainable autoinjector development
Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction. -
News Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes.
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance